Outcome and prognostic factors of childhood diffuse brainstem glioma
- PMID: 19956489
- PMCID: PMC2785398
- DOI: 10.4143/crt.2005.37.2.109
Outcome and prognostic factors of childhood diffuse brainstem glioma
Abstract
Purpose: The outcome and prognostic factors of brainstem glioma were evaluated following radiotherapy methods.
Materials and methods: Between 1986 and 2001, 45 childhood patients with diffuse brainstem glioma were treated. There were 26 boys and 19 girls, with a median age of 7 years (range 3 approximately 18). The histopathological diagnoses were confirmed in 13 patients, which revealed a low-grade glioma in four patients, and high-grade glioma in the other nine. Before 1993, radiation therapy using a regime of 1.8 to 2.0 Gy once a day was performed in 16 cases; thereafter, a regimes of 1.1 or 1.5 Gy twice a day was given in 15 and 14 cases, respectively. Nine patients were treated with adjuvant chemotherapy. The response to the treatment was evaluated by the MRI findings 4 weeks after radiotherapy.
Results: After radiotherapy, the neurological deficit improved in 42 of the 45 patients (93%). The MRI responses were as follows; partial response 22/39 (56%), minimal to no response in 16/39 (41%) and tumor progression in 1/39 (3%). The median time to disease progression was 7 months, and the median survival was 12 months; the overall survival rate at 1 year was 41%. There was no significant prognostic factor for overall survival. The progression-free survival was influenced by the tumor histology (low grade vs. high grade, p=0.05) in those patients whose pathology was confirmed.
Conclusion: The radiation therapy fractionation schedule did not influence the survival. Low grade histology was a possible favorable prognostic factor of progression-free survival in pediatric brainstem glioma patients.
Keywords: Brainstem glioma; Radiotherapy.
Figures
References
-
- Reigel DH, Scarff TB, Woodford JE. Biopsy of pediatric brainstem tumors. Childs Brain. 1979;5:329–340. - PubMed
-
- Zimmerman RA. Neuroimaging of pediatric brain stem diseases other than brain stem glioma. Pediatr Neurosurg. 1996;25:83–92. - PubMed
-
- Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain-stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys. 1993;27:197–206. - PubMed
-
- Kaplan AM, Albright AL, Zimmerman RA, Rorke LB, Li H, Boyett JM, et al. Brainstem gliomas in children. A Children's Cancer Croup review of 119 cases. Pediatr Neurosurg. 1996;24:185–192. - PubMed
-
- Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;43:959–964. - PubMed
LinkOut - more resources
Full Text Sources
